Bleeding risk assessment during oral anticoagulant therapy initiation

References

• Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke. JAMA 285(22), 2864–2870 (2001).
   PubMed Web of Science ®Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 137(2), 263–272 (2010).
   PubMed Web of Science ®Google Scholar
• Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl.), 546S–592S (2008).
   PubMed Web of Science ®Google Scholar
• Rodger MA, Kahn SR, Wells PS et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179(5), 417–426 (2008).
   PubMed Web of Science ®Google Scholar
• Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism. Circulation 121(14), 1630–1636 (2010).
   PubMed Web of Science ®Google Scholar
• Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann. Intern. Med. 139(11), 893–900 (2003).
   PubMed Web of Science ®Google Scholar
• Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann. Intern. Med. 152(9), 578–589 (2010).
   PubMed Web of Science ®Google Scholar
• Lip GY, Andreotti F, Fauchier L et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb. Haemost. 106(6), 997–1011 (2011).
   PubMed Web of Science ®Google Scholar
• Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am. J. Med. 105(2), 91–99 (1998).
   PubMed Web of Science ®Google Scholar
• Kuijer PM, Hutten BA, Prins MH, Buller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch. Intern. Med. 159(5), 457–460 (1999).
   PubMed Web of Science ®Google Scholar
• Kearon C, Ginsberg JS, Kovacs MJ et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N. Engl. J. Med. 349(7), 631–639 (2003).
   PubMed Web of Science ®Google Scholar
• Ruiz-Gimenez N, Suarez C, Gonzalez R et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb. Haemost. 100(1), 26–31 (2008).
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J. Am. Coll. Cardiol. 58(4), 395–401 (2011).
   PubMed Web of Science ®Google Scholar
• Gage BF, Yan Y, Milligan PE et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am. Heart J. 151(3), 713–719 (2006).
   PubMed Web of Science ®Google Scholar
• Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J. Am. Coll. Cardiol. 57(2), 173–180 (2011).
   PubMed Web of Science ®Google Scholar
• Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 130(5), 1390–1396 (2006).
   PubMed Web of Science ®Google Scholar
• Burgess S, Crown N, Louzada ML, Dresser G, Kim R, Lazo-Langner A. Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving oral anticoagulant therapy. Blood 118(21), Abstract 2311 (2011).
   Google Scholar
• Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277(6), 488–494 (1997).
   PubMed Web of Science ®Google Scholar
• Eddy DM. Clinical decision making: from theory to practice. Anatomy of a decision. JAMA 263(3), 441–443 (1990).
   PubMed Web of Science ®Google Scholar
• Lazo-Langner A, Rodger MA, Barrowman NJ, Ramsay T, Wells PS, Coyle DA. Comparing multiple competing interventions in the absence of randomized trials using clinical risk–benefit analysis. BMC Med. Res. Methodol. 12(1), 3 (2012).
   PubMedGoogle Scholar